老年糖尿病患者治疗:内分泌学会临床实践指南
该指南由内分泌学会制定,针对老年(尤其65岁以上)糖尿病患者的治疗提出临床实践建议。指南强调老龄化对代谢调节的直接影响及与糖尿病交互加速并发症,旨在指导医疗提供者避免不必要或有害的不良反应,惠及1型和2型老年糖尿病患者。
要点
- 老年糖尿病患病率随年龄增长而增加,尤其65岁以上人群。
- 老龄化直接影响代谢调节,并与糖尿病交互加速并发症进展。
- 治疗应重点关注避免不必要和/或有害的不良反应。
核心结论
- 糖尿病(尤其2型)在老年人群中日益普遍,老龄化影响代谢调节并与糖尿病交互加速并发症。
- 指南旨在为医疗提供者提供指导,使老年1型和2型糖尿病患者获益,特别注意避免不必要和/或有害的不良反应。
研究设计与样本
- 由内分泌学会制定的临床实践指南,各章节基于控试验等证据综述病因和治疗选择及结局。
临床怎么用
- 临床医生治疗老年糖尿病患者时应特别关注避免不必要和/或有害的不良反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective is to formulate clinical practice guidelines for the treatment of diabetes in older adults. CONCLUSIONS: Diabetes, particularly type 2, is becoming more prevalent in the general population, especially in individuals over the age of 65 years. The underlying pathophysiology of the disease in these patients is exacerbated by the direct effects of aging on metabolic regulation. Similarly, aging effects interact with diabetes to accelerate the progression of many common diabetes complications. Each section in this guideline covers all aspects of the etiology and available evidence, primarily from controlled trials, on therapeutic options and outcomes in this population. The goal is to give guidance to practicing health care providers that will benefit patients with diabetes (both type 1 and type 2), paying particular attention to avoiding unnecessary and/or harmful adverse effects.
引用
- LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019. PMID: 30903688. doi:10.1210/jc.2019-00198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。